Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deployment of other neurovascular devices and to allow flow arrest during mechanical thrombectomy procedures performed in subjects experiencing acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) and treated within 24 hours of symptom onset.

Participants needed: 327
Trial details
Age: 22-85Biological sex: AllType: InterventionalSponsor: Anaconda Biomed S.L.Updated: Dec 11, 2025Locations: 22
Eligibility criteria

Age 22 to 85 years. [+10]

Subject was diagnosed with a stroke in the past year. [+18]

Status: Recruiting

Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke

The goal of this study is to evaluate the safety and performance of the CONDA stent retriever in patients with acute ischemic stroke due to large vessel occlusion, treated within 24 hours of symptom onset. The main objectives are: * To determine the rate of device success, defined as the ability of the CONDA retriever to reach the blocked vessel, be deployed and retrieved successfully, and facilitate reperfusion. * To evaluate safety, measured as the rate of symptomatic intracranial hemorrhage within 24 hours of the procedure. The use of CONDA in this study follows the same approach as other CE-marked stent retrievers. Supportive devices (such as long sheaths, guide catheters, balloon catheters, distal access catheters, the ANA funnel catheter, microcatheters, and microwires) may be used according to investigator preference and local practice, in line with their labeling and instructions for use. Participants will: * Be evaluated using standard clinical and imaging assessments to confirm eligibility. * Undergo mechanical thrombectomy with the CONDA device, with or without supportive devices as selected by the treating physician. * Have standard follow-up evaluations to assess treatment safety and effectiveness.

Participants needed: 50
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Anaconda Biomed S.L.Updated: Sep 16, 2025Locations: 2
Eligibility criteria

Age 18 to 85 years. [+11]

Rapid neurological improvement prior to enrollment suggesting resolution of stro... [+28]